[A new nonsteroidal anti-inflammatory agent: bucloxic acid (804 CB)].
D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000138:chemical synthesis / Q000627:therapeutic use / Q000633:toxicity; D002118:Calcium / Q000627:therapeutic use; D002351:Carrageenan; D003510:Cyclohexanes / Q000138:chemical synthesis / Q000627:therapeutic use / Q000633:toxicity; D004487:Edema / Q000188:drug therapy; D006099:Granuloma / Q000188:drug therapy; D007651:Keto Acids / Q000138:chemical synthesis / Q000627:therapeutic use / Q000633:toxicity; D007928:Lethal Dose 50; D051379:Mice; D010654:Phenylbutyrates / Q000138:chemical synthesis / Q000627:therapeutic use / Q000633:toxicity; D051381:Rats; D012964:Sodium / Q000627:therapeutic use; D013329:Structure-Activity Relationship
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D003510:Cyclohexanes; D007651:Keto Acids; D010654:Phenylbutyrates; D002351:Carrageenan; D012964:Sodium; D002118:Calcium
Sur un nouvel anti-inflammatoire non stéroidique: l'acide bucloxique (804 CB)